Earlier this week Majestic Research, an independent research company that provides institutional investors primary research based on large commercial databases, announced its acquisition of Rood Research, a healthcare market research firm.
Majestic converts raw data into metrics which can be used by investors to identify emerging revenue trends. Sectors covered include airlines, auto retail, casinos, consumer technology, cruise lines, eCommerce, homebuilders, and pharma & biotech. In each of these sectors, Majestic has access to a large volume of information which it then uses to gain insight into the market. “Integrating Rood’s healthcare research into the Majestic platform will enhance our current offering in the sector and establish our initial footprint in the market research arena,” said Tony Berkman, CEO of Majestic Research.
Rood Research is a supplier of heath care industry research and consulting. Areas of focus include pharmaceuticals, biotech, devices technologies, and managed care.
We have included the Press Release below:
NEW YORK, New York–Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, today announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research. While many companies have been forced to downsize in this economic environment, Majestic continues to expand its breadth of offerings into the financial services and market research space.
“Majestic has built its reputation on our ability to provide substantial depth and innovative analysis across a broad range of sectors. Integrating Rood’s healthcare research into the Majestic platform will enhance our current offering in the sector and establish our initial footprint in the market research arena,” said Tony Berkman, CEO of Majestic Research. This acquisition exemplifies the company’s continued growth and reinforces the success of its revolutionary research model. “We are excited to be joining forces with a company that complements our strengths. By combining the innovation and experience of two pioneers in research, we are well-equipped to meet the diverse needs of our clients even in the most challenging economic environment,” says Edith Rood, CEO and founder of Rood Research.
About Rood Research
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world. Their timely research incorporates proprietary methodologies and processes with the help of a team of highly credentialed, experienced and dedicated healthcare researchers. Rood’s depth of coverage includes all therapeutic areas and all healthcare industry segments.
About Majestic Research
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. While traditional equity research is frequently based on publicly available data, anecdotal information and channel checks of limited sample sizes, Majestic leverages its exclusive relationships with proprietary industry data providers and our proprietary Web harvesting technology to generate fresh insights from superior analysis of millions of data points.
Many of the largest and most respected hedge funds and mutual funds in the world look to us for our unique insights and groundbreaking methodologies. Majestic has no investment banking relationships and does not offer Buy or Sell recommendations. Our sole mission is to provide our clients with the market insight to stay ahead of the Street, make smarter investment decisions, and improve their performance.